Rocket Pharmaceuticals Stock Forecast

Buy candidate since Aug 05, 2026 Gain 4.00%

The Rocket Pharmaceuticals Inc stock price gained 0.83% on the last trading day (Monday, 10th Aug 2026), rising from $3.61 to $3.64. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 4.80% from a day low at $3.54 to a day high of $3.71. The price has risen in 7 of the last 10 days and is up by 12% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 35 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $4.93 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.05% during the next 3 months and, with a 90% probability hold a price between $3.32 and $5.01 at the end of this 3-month period.

RCKT Signals & Forecast

Mostly positive signals in the chart today. The Rocket Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $3.46 and $3.51. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, July 31, 2026, and so far it has risen 17.04%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Rocket Pharmaceuticals Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.35 and $3.25. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Rocket Pharmaceuticals Inc finds support just below today's level at $3.35. If this is broken, then the next support from accumulated volume will be at $3.25 and $2.92.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.170 between high and low, or 4.80%. For the last week, the stock has had daily average volatility of 4.57%.

Since the Rocket Pharmaceuticals Inc has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $3.50 (-3.78%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (RCKT) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Rocket Pharmaceuticals Inc to open at $3.63, and during the day (based on 14 day Average True Range), to move between $3.54 and $3.74, which gives a possible trading interval of +/-$0.196 (+/-5.53%) up or down from last closing price. If Rocket Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 5.53% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.35 (7.97%) than the resistance at $3.99 (9.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Rocket Pharmaceuticals Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Rocket Pharmaceuticals Inc stock to perform well in the short-term.

Current score: 2.202 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $3.63 ( 0.276%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk